←
@MacMODR1,266 posts
@MacMODR avatar

@MacMODR

@MacMODR

McMaster's Centre for Metabolism, Obesity & Diabetes Research translates world leading basic science into clinical practice to improve metabolic disease.

◷ Joined January 2019▧ 534 Photos and videos
Eric M. Desjardins avatar
⟳ @MacMODR retweeted
Eric M. Desjardins@EricMDesjardins·1 Aug 2025

Targeting hepatocyte and tumour lipid metabolism through ACLY inhibition promotes B-cell infiltration/aggregation via CXCL13, resulting in reduced tumour burden in MASH-HCC mouse models nature.com/articles/s41586-0…

@MacMODR avatar
@MacMODR@MacMODR·31 Jul 2025

“This is one of the first studies to show that targeting metabolism in tumours can enable the immune system to kill liver cancer cells, and opens the door to more effective prevention and treatment strategies for this deadly disease,” @DrGregSteinberg healthsci.mcmaster.ca/mcmast…

McMaster Health Sciences avatar
⟳ @MacMODR retweeted
McMaster Health Sciences@machealthsci·29 Jul 2025

Researchers from across @McMasterU’s Faculty of Health Sciences have secured nearly $19M from @CIHR_IRSC’s Spring 2025 Project Grant Competition. Explore the full list of newly funded research teams and topics 👇 ow.ly/V8ab50WwI1S

McMaster Health Sciences avatar
⟳ @MacMODR retweeted
McMaster Health Sciences@machealthsci·30 Jul 2025

Researchers with @MacDeptMed have developed a promising new treatment that helps the immune system attack and kill tumours associated with severe fatty liver disease. @DrGregSteinberg ow.ly/rjCe50WxwMi

@MacMODR avatar
@MacMODR@MacMODR·30 Jul 2025

Published in @Nature, the findings offer a promising path to better prevention & treatment strategies. nature.com/articles/s41586-0…

@MacMODR@MacMODR30 Jul 2025

Liver cancer rates are📈in Canada, driven by #fattyliverdisease 🔗to #obesity & #diabetes. Current treatments are limited. Researchers @MacMODR & #EspervitaTherapeutics developed a drug that blocks fat production in tumors, helping #Bcells attack cancer.

Post attachment
Jonathan Schertzer (SchertzerLab) avatar
⟳ @MacMODR retweeted
Jonathan Schertzer (SchertzerLab)@SchertzerLab·29 Jul 2025

Gut substrate trap of D-lactate from microbiota improves blood glucose and fatty liver disease in obese mice: Cell Metabolism cell.com/cell-metabolism/ful…

Daniel J Drucker avatar
⟳ @MacMODR retweeted
Daniel J Drucker@DanielJDrucker·29 Jul 2025

Here Professor Schertzer and colleagues identify that microbial-derived D-lactate contributes to host glucose and lipid metabolism and can be trapped therapeutically to improve metabolic disease during #obesity cell.com/cell-metabolism/ful…

McMaster Health Sciences avatar
⟳ @MacMODR retweeted
McMaster Health Sciences@machealthsci·29 Jul 2025

Researchers from @McMasterU @universitelaval @uOttawa have made a discovery that could open the door to new therapies to treat metabolic diseases like type 2 diabetes and fatty liver disease. Learn more: healthsci.mcmaster.ca/trappi… @CIHR_IRSC @Farncombe_GI @MacMODR